The Cap-Snatching SFTSV Endonuclease Domain Is an Antiviral Target

doi:10.1016/j.celrep.2019.12.020

Title: The Cap-Snatching SFTSV Endonuclease Domain Is an Antiviral Target

Full Record
Other Related Research

Authors:: Wang, Wenjie; Shin, Woo-Jin; Zhang, Bojie; Choi, Younho; Yoo, Ji-Seung; Zimmerman, Maxwell I.; Frederick, Thomas E.; Bowman, Gregory R.; Gross, Michael L.; Leung, Daisy W.; Jung, Jae U.; Amarasinghe, Gaya K.

Publication Date:: 2020-01-01

Sponsoring Org.:: USDOE

OSTI Identifier:: 1581467

Grant/Contract Number:: AC02-05CH11231

Resource Type:: Published Article

Journal Name:: Cell Reports

Additional Journal Information:: Journal Name: Cell Reports Journal Volume: 30 Journal Issue: 1; Journal ID: ISSN 2211-1247

Publisher:: Elsevier

Country of Publication:: Netherlands

Language:: English

Citation Formats


                    Wang, Wenjie, Shin, Woo-Jin, Zhang, Bojie, Choi, Younho, Yoo, Ji-Seung, Zimmerman, Maxwell I., Frederick, Thomas E., Bowman, Gregory R., Gross, Michael L., Leung, Daisy W., Jung, Jae U., and Amarasinghe, Gaya K. The Cap-Snatching SFTSV Endonuclease Domain Is an Antiviral Target.  Netherlands: N. p., 2020. 
        Web.  doi:10.1016/j.celrep.2019.12.020.

Copy to clipboard


                    Wang, Wenjie, Shin, Woo-Jin, Zhang, Bojie, Choi, Younho, Yoo, Ji-Seung, Zimmerman, Maxwell I., Frederick, Thomas E., Bowman, Gregory R., Gross, Michael L., Leung, Daisy W., Jung, Jae U., & Amarasinghe, Gaya K. The Cap-Snatching SFTSV Endonuclease Domain Is an Antiviral Target.  Netherlands.  doi:10.1016/j.celrep.2019.12.020.

Copy to clipboard


                    Wang, Wenjie, Shin, Woo-Jin, Zhang, Bojie, Choi, Younho, Yoo, Ji-Seung, Zimmerman, Maxwell I., Frederick, Thomas E., Bowman, Gregory R., Gross, Michael L., Leung, Daisy W., Jung, Jae U., and Amarasinghe, Gaya K. Wed .  
        "The Cap-Snatching SFTSV Endonuclease Domain Is an Antiviral Target".  Netherlands.  doi:10.1016/j.celrep.2019.12.020.

Copy to clipboard


                    
@article{osti_1581467,

  title        = {The Cap-Snatching SFTSV Endonuclease Domain Is an Antiviral Target},

  author       = {Wang, Wenjie and Shin, Woo-Jin and Zhang, Bojie and Choi, Younho and Yoo, Ji-Seung and Zimmerman, Maxwell I. and Frederick, Thomas E. and Bowman, Gregory R. and Gross, Michael L. and Leung, Daisy W. and Jung, Jae U. and Amarasinghe, Gaya K.},

  abstractNote = {},

  doi          = {10.1016/j.celrep.2019.12.020},

  journal      = {Cell Reports},

  number       = 1,

  volume       = 30,

  place        = {Netherlands},

  year         = {2020},

  month        = {1}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
DOI: 10.1016/j.celrep.2019.12.020

Other availability

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar records in OSTI.GOV collections:

Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors

Journal Article Jones, Jeremy C. ; Kumar, Gyanendra ; Barman, Subrata ; ... - mBio (Online)

ABSTRACT The clinical severity and annual occurrence of influenza virus epidemics, combined with the availability of just a single class of antivirals to treat infections, underscores the urgent need to develop new anti-influenza drugs. The endonuclease activity within the viral acidic polymerase (PA) protein is an attractive target for drug discovery due to the critical role it plays in viral gene transcription. RO-7 is a next-generation PA endonuclease inhibitor of influenza A and B viruses, but its drug resistance potential is unknown. Through serial passage of influenza A(H1N1) viruses in MDCK cells under selective pressure of RO-7, we identified anmore »« less
Cited by 6
DOI: 10.1128/mBio.00430-18
Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors

Journal Article Jones, Jeremy C. ; Kumar, Gyanendra ; Barman, Subrata ; ... - mBio (Online)

ABSTRACT The clinical severity and annual occurrence of influenza virus epidemics, combined with the availability of just a single class of antivirals to treat infections, underscores the urgent need to develop new anti-influenza drugs. The endonuclease activity within the viral acidic polymerase (PA) protein is an attractive target for drug discovery due to the critical role it plays in viral gene transcription. RO-7 is a next-generation PA endonuclease inhibitor of influenza A and B viruses, but its drug resistance potential is unknown. Through serial passage of influenza A(H1N1) viruses in MDCK cells under selective pressure of RO-7, we identified anmore »« less
DOI: 10.1128/mBio.00430-18
Magnesium-Dependent RNA Binding to the PA Endonuclease Domain of the Avian Influenza Polymerase

Journal Article Xiao, Shiyan ; Klein, Michael L. ; LeBard, David N. ; ... - Journal of Physical Chemistry. B, Condensed Matter, Materials, Surfaces, Interfaces and Biophysical Chemistry

Influenza A viruses are highly pathogenic and pose an unpredictable public health danger to humans. An attractive target for developing new antiviral drugs is the PA N-terminal domain (PAN) of influenza polymerase, which is responsible for the endonuclease activity and essential for viral replication. Recently, the crystal structures of the holo form of PAN as well as PAN bound to different inhibitors have been reported, but the potency and selectivity of these inhibitors still need to be improved. New drug design can be guided by a better understanding of the endonuclease activity of PAN. However, this requires the structure ofmore »« less
DOI: 10.1021/jp408383g
Structure of the Antiviral Assembly Inhibitor CAP-1 Complex with the HIV-1 CA Protein

Journal Article Kelly,B. ; Kyere, S. ; Kinde, I. ; ... - Journal of Molecular Biology

The CA domain of the human immunodeficiency virus type 1 (HIV-1) Gag polyprotein plays critical roles in both the early and late phases of viral replication and is therefore an attractive antiviral target. Compounds with antiviral activity were recently identified that bind to the N-terminal domain of CA (CA{sup N}) and inhibit capsid assembly during viral maturation. We have determined the structure of the complex between CA{sup N} and the antiviral assembly inhibitor N-(3-chloro-4-methylphenyl)-N'-{l_brace}2-[({l_brace}5-[(dimethylamino)-methyl]-2-furyl{r_brace}-methyl)-sulfanyl]ethyl{r_brace}-urea (CAP-1) using a combination of NMR spectroscopy and X-ray crystallography. The protein undergoes a remarkable conformational change upon CAP-1 binding, in which Phe32 is displaced frommore »« less
DOI: 10.1016/j.jmb.2007.07.070
Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins

Journal Article Zhao, Baoyu ; Shu, Chang ; Gao, Xinsheng ; ... - Proceedings of the National Academy of Sciences of the United States of America

Type I IFNs are key cytokines mediating innate antiviral immunity. cGMP-AMP synthase, ritinoic acid-inducible protein 1 (RIG-I)–like receptors, and Toll-like receptors recognize microbial double-stranded (ds)DNA, dsRNA, and LPS to induce the expression of type I IFNs. These signaling pathways converge at the recruitment and activation of the transcription factor IRF-3 (IFN regulatory factor 3). The adaptor proteins STING (stimulator of IFN genes), MAVS (mitochondrial antiviral signaling), and TRIF (TIR domain-containing adaptor inducing IFN-β) mediate the recruitment of IRF-3 through a conserved pLxIS motif. Here in this paper, we show that the pLxIS motif of phosphorylated STING, MAVS, and TRIF bindsmore »« less
DOI: 10.1073/pnas.1603269113

Full Text Available

Similar Records